These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38416659)

  • 21. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
    Yetkin O; Gunen H
    Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developing a New Marker of Dynamic Hyperinflation in Patients with Obstructive Airway Disease - an observational study.
    Chuang ML; Hsieh MJ; Wu TC; Lin IF
    Sci Rep; 2019 May; 9(1):7514. PubMed ID: 31101856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inspiratory Capacity as an Indirect Measure of Immediate Effects of Positive Expiratory Pressure and CPAP Breathing on Functional Residual Capacity in Healthy Subjects.
    Sehlin M; Winsö O; Wadell K; Öhberg F
    Respir Care; 2015 Oct; 60(10):1486-94. PubMed ID: 26152469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conical-PEP is safe, reduces lung hyperinflation and contributes to improved exercise endurance in patients with COPD: a randomised cross-over trial.
    Padkao T; Boonsawat W; Jones CU
    J Physiother; 2010; 56(1):33-9. PubMed ID: 20500135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal changes in handgrip strength, hyperinflation, and 6-minute walk distance in patients with COPD and a control group.
    Felipe C; Bartolome C; Miguel D; Victor PP
    Chest; 2015 Oct; 148(4):986-994. PubMed ID: 25996450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung hyperinflation and functional exercise capacity in patients with COPD - a three-year longitudinal study.
    Aalstad LT; Hardie JA; Espehaug B; Thorsen E; Bakke PS; Eagan TML; Frisk B
    BMC Pulm Med; 2018 Dec; 18(1):187. PubMed ID: 30522466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of dynamic lung hyperinflation and tidal volume to total lung capacity ratios during exercise in patients with chronic respiratory disease and healthy individuals.
    Chuang ML
    Respir Physiol Neurobiol; 2023 Oct; 316():104124. PubMed ID: 37499989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small airway impairment in moderate to severe asthmatics without significant proximal airway obstruction.
    Perez T; Chanez P; Dusser D; Devillier P
    Respir Med; 2013 Nov; 107(11):1667-74. PubMed ID: 24025779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inspiratory capacity-to-total lung capacity ratio and dyspnoea predict exercise capacity decline in COPD.
    Ramon MA; Ferrer J; Gimeno-Santos E; Donaire-Gonzalez D; Rodríguez E; Balcells E; de Batlle J; Benet M; Guerra S; Sauleda J; Ferrer A; Farrero E; Gea J; Barberà JA; Agustí A; Rodriguez-Roisin R; Antó JM; Garcia-Aymerich J;
    Respirology; 2016 Apr; 21(3):476-82. PubMed ID: 26714424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
    McIlwaine M; Button B; Nevitt SJ
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31774149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity Impact on Dyspnea in COPD Patients.
    Dupuis A; Thierry A; Perotin JM; Ancel J; Dormoy V; Dury S; Deslée G; Launois C
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1695-1706. PubMed ID: 39070800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio.
    Cardoso J; Coelho R; Rocha C; Coelho C; Semedo L; Bugalho Almeida A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1105-1113. PubMed ID: 29670346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A reappraisal of inspiratory capacity in chronic obstructive pulmonary disease: clinical correlates and role of long-acting muscarinic antagonists and long-acting β2 agonists.
    Danzo F; Radovanovic D; Gatti M; Saad M; Perotto L; Franceschi E; Santus P
    Expert Rev Respir Med; 2022 Jun; 16(6):623-635. PubMed ID: 35722753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
    Cooper CB
    Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early COPD patients with lung hyperinflation associated with poorer lung function but better bronchodilator responsiveness.
    Chen C; Jian W; Gao Y; Xie Y; Song Y; Zheng J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2519-2526. PubMed ID: 27785008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of bronchodilator responses in patients with "irreversible" emphysema.
    O'Donnell DE; Forkert L; Webb KA
    Eur Respir J; 2001 Dec; 18(6):914-20. PubMed ID: 11829096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of effectiveness of temporary positive expiratory pressure versus oscillatory positive expiratory pressure in severe COPD patients.
    Nicolini A; Mascardi V; Grecchi B; Ferrari-Bravo M; Banfi P; Barlascini C
    Clin Respir J; 2018 Mar; 12(3):1274-1282. PubMed ID: 28665556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tidal volume expandability affected by flow, dynamic hyperinflation, and quasi-fixed inspiratory time in patients with COPD and healthy individuals.
    Chuang ML
    Chron Respir Dis; 2022; 19():14799731221133390. PubMed ID: 36210794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.